FeesSafety
Pluang+

INVO Fertility announces 1-for-4 reverse stock split effective October 30, 2026

Company Fundamentals
28 Oct 2026, 01:00 WIB
GlobeNewsWire
View Source
Neutral
INVO Fertility announces 1-for-4 reverse stock split effective October 30, 2026

INVO Fertility, a healthcare company specializing in fertility clinics and technologies, will implement a 1-for-4 reverse stock split effective October 30, 2026. This means every 4 shares will be consolidated into 1 share, reducing the total shares outstanding to approximately 1.19 million. The stock will continue trading under the symbol "IVF" on Nasdaq. This move aims to adjust the company's share structure, potentially improving stock price stability and marketability.

INVO Fertility's upcoming 1-for-4 reverse stock split is noted here for context. For readers following the health sector, 90 of 150 US health stocks rose while 60 fell as of Oct 28, 2026 05:02 WIB. Notable movers include BFLY at USD 7.41 (+11.26%), TWST at USD 160.70 (+10.64%) with 100% buy orders on Pluang, and IBRX at USD 8.61 (+10.24%) with 100% buy orders.

More News

Drone defense market to hit $18.19B by 2030 with 30.6% CAGR amid rising security threats

Drone defense market to hit $18.19B by 2030 with 30.6% CAGR amid rising security threats

The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...

Market News
Bullish
1 hour ago
Vallourec to release Q3 2026 results on Nov 20 with CEO and CFO presentation.

Vallourec to release Q3 2026 results on Nov 20 with CEO and CFO presentation.

Vallourec will publish its Q3 2026 financial results on November 20, 2026, at 07:30 AM CET. The company's CEO Philippe Guillemot and CFO Nathalie Delbreuve will present the results via a conference call and webcast at 09:30 AM CET the same day. Inves...

Company Fundamentals
Neutral
4 hours ago
Clearfield schedules Q4 2026 earnings call for Nov 10 to discuss financial results.

Clearfield schedules Q4 2026 earnings call for Nov 10 to discuss financial results.

Clearfield, Inc. announced it will release its fiscal fourth quarter 2026 earnings on November 10, 2026, after market close. The company will hold a conference call at 5:00 p.m. Eastern time to discuss the results with investors. Financial details an...

Company Fundamentals
Neutral
4 hours ago
Law firm probes Enova International over possible securities fraud after bank deal collapse.

Law firm probes Enova International over possible securities fraud after bank deal collapse.

Pomerantz LLP is investigating claims against Enova International and some of its executives for potential securities fraud following Enova's withdrawal of its application to acquire Grasshopper Bancorp, which would have made it a bank holding compan...

Market News
Bearish
4 hours ago
Nektar Therapeutics to report Q3 2026 earnings on Nov 12 with CEO conference call

Nektar Therapeutics to report Q3 2026 earnings on Nov 12 with CEO conference call

Nektar Therapeutics will announce its financial results for the third quarter ending September 30, 2026, on November 12 after U.S. markets close. CEO Howard Robin will host a conference call to discuss the results at 5:00 p.m. Eastern Time. The call ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App